Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

Clinical trial NCT01535261 · COMPLETED

Trial details

NCT number: NCT01535261
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Macular Edema Central Retinal Vein Occlusion

Start date: 2012-02-01
Primary completion: 2015-03-01
Enrollment: 357

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.